The Bipolar Big Three: LAIs, Atypical Antipsychotics And Symptom Specific Drugs

Room For Growth Beyond Generics

 
• By Ayisha Sharma

Despite the highly genericized nature of the bipolar disorder market, firms have innovated with long-acting injectables, improved atypical antipsychotics and drugs targeting specific symptoms.  

Two-headed silhouette, mental health disorder concept.
BD Is Influenced By Social, Environmental And Genetic Factors • Source: Alamy

More from Neurological

More from Therapy Areas